Boardroom Alpha
Boardroom Alpha
ADTN · Current Report (Form 8-K) · Filed May 18, 2026

Adtran Holdings Inc — Current Report (Form 8-K)

Form
8-K
Filed
May 18, 2026
Period
May 13, 2026
Ticker
ADTN
Accession
0001193125-26-228208
Boardroom Alpha · Filing insights

Stockholders approved a Charter Amendment to limit officer liability under Delaware law. They elected six directors and ratified PwC.

About Adtran Holdings Inc
Market cap
$1.5B
1Y TSR
+95.9%
3Y TSR
+18.0%
Board grade
C
Sector
Technology
CEO
Thomas R Stanton
Last annual meeting: May 13, 2026 · View full Adtran Holdings Inc profile →
8-K

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 13, 2026

 

 

ADTRAN Holdings, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-41446

87-2164282

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

901 Explorer Boulevard

 

Huntsville, Alabama

 

35806-2807

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (256) 963-8000

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, Par Value $0.01 per share

 

ADTN

 

Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

At the Annual Meeting of Stockholders held by ADTRAN Holdings, Inc. (the “Company”) on May 13, 2026 (the “2026 Annual Meeting”), the Company’s stockholders approved an amendment (the “Charter Amendment”) to the Company’s Amended and Restated Certificate of Incorporation (the “Charter”). As further described in Proposal 2 of the Company’s definitive proxy statement filed with the Securities and Exchange Commission on March 27, 2026, the Charter Amendment provides for the elimination of monetary liability (i.e., exculpation) of certain officers of the Company in the limited circumstances permitted under Delaware law and made certain additional changes to Section 7.1 of the Charter. The Charter Amendment became effective upon the filing of a Certificate of Amendment (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware on May 13, 2026.

The foregoing summary is not complete and is qualified in its entirety by reference to the full text of the Certificate of Amendment, a copy of which is filed as Exhibit 3.1 and incorporated by reference herein.

Item 5.07 Submission of Matters to a Vote of Security Holders.

At the 2026 Annual Meeting, the Company’s stockholders (i) elected six directors to serve on the board of directors of the Company (the “Board”) for a one-year term expiring at the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified (Proposal 1); (ii) approved the Charter Amendment to limit the liability of certain officers as permitted by Delaware law and to make certain other changes to Section 7.1 thereof (Proposal 2); (iii) approved, on an advisory basis, the compensation of the Company’s named executive officers (Proposal 3); and (iv) ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026 (Proposal 4). The voting results for these proposals are presented in the tables below:

Proposal 1 - Election of Directors

 

 

For

 

 

Against

 

 

Abstain

 

 

Broker Non-Votes

 

Thomas R. Stanton

 

 

48,261,250

 

 

 

4,686,183

 

 

 

65,014

 

 

 

9,313,693

 

H. Fenwick Huss

 

 

49,570,974

 

 

 

3,375,771

 

 

 

65,702

 

 

 

9,313,693

 

Gregory J McCray

 

 

50,408,661

 

 

 

2,500,847

 

 

 

102,939

 

 

 

9,313,693

 

Jacqueline H. Rice

 

 

48,662,681

 

 

 

4,290,891

 

 

 

58,875

 

 

 

9,313,693

 

Nikos Theodosopoulos

 

 

50,543,871

 

 

 

2,408,380

 

 

 

60,196

 

 

 

9,313,693

 

Kathryn A. Walker

 

 

51,399,106

 

 

 

1,555,109

 

 

 

58,232

 

 

 

9,313,693

 

Proposal 2 - Amendment to Amended and Restated Certificate of Incorporation to Limit the Liability of Certain Officers as Permitted by Delaware Law and to Make Certain Other Changes to Section 7.1 Thereof

For

 

 

Against

 

 

Abstain

 

 

Broker Non-Votes

 

 

49,777,494

 

 

 

3,184,044

 

 

 

50,909

 

 

 

9,313,693

 

Proposal 3 - Advisory Vote Regarding the Compensation of the Company's Named Executive Officers

For

 

 

Against

 

 

Abstain

 

 

Broker Non-Votes

 

 

49,881,975

 

 

 

3,077,276

 

 

 

53,196

 

 

 

9,313,693

 

Proposal 4 - Ratification of the Appointment of PricewaterhouseCoopers LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026

For

 

 

Against

 

 

Abstain

 

 

61,869,565

 

 

 

413,517

 

 

 

43,058

 

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit Number

 

Description

3.1

Certificate of Amendment to the Certificate of Incorporation of ADTRAN Holdings, Inc., effective as of May 13, 2026

104

Cover Page Interactive Data File – the cover page iXBRL tags are embedded within the Inline XBRL document

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

ADTRAN Holdings, Inc.

 

 

 

 

Date:

May 18, 2026

By:

/s/ Timothy Santo

 

 

 

Timothy Santo
Senior Vice President of Finance and
Chief Financial Officer
 

 


From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Adtran Holdings Inc (ADTN)

Reference

Frequently asked questions

When did Adtran Holdings Inc file this 8-K?
Adtran Holdings Inc (ADTN) filed this Current Report (Form 8-K) with the SEC on May 18, 2026. The accession number assigned by EDGAR is 0001193125-26-228208.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Stockholders approved a Charter Amendment to limit officer liability under Delaware law. They elected six directors and ratified PwC. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Adtran Holdings Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Adtran Holdings Inc has filed under CIK 926282, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer